Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric derisomaltose for postoperative anemia in cardiac surgery
NCT07238972Phase 4Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Dec 2025
- Primary completion
- Aug 2030
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric derisomaltose in postoperative anemia, iron deficiency anemia (IDA), sponsored by Yonsei University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
postoperative anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07238972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07238972.